Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis

Mostrar otras versiones (1)

PURPOSE: Contemporary, real-world data on eligible patients receiving treatment following progression on first-line (1L) recurrent or metastatic cervical cancer (r/mCC) therapy are needed to inform treatment algorithms and identify potential gaps in the r/mCC care continuum. METHODS: This study esti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonawane, Kalyani, Castellano, Tara, Washington, Christina, Ting, Jie, Surinach, Andy, Kirshner, Carol, Chhatwal, Jagpreet, Ayer, Turgay, Moore, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731386/
https://www.ncbi.nlm.nih.gov/pubmed/36506039
http://dx.doi.org/10.1016/j.gore.2022.101101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731386/
https://www.ncbi.nlm.nih.gov/pubmed/36506039
http://dx.doi.org/10.1016/j.gore.2022.101101

Ejemplares similares